GSK Signs Cancer Deal with SuperGen

By Taskin Ahmed

PharmaDeals Review: Vol 2009 Issue 10 (Table of Contents)

Published: 30 Oct-2009

DOI: 10.3833/pdr.v2009i10.1263     ISSN: 1756-7874

Section: Research & Development

Fulltext:

Abstract

SuperGen has signed a multi-year collaboration deal with GlaxoSmithKline to discover and develop cancer therapeutics based on epigenetic targets...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login on the top right purple box.

Copyright: PharmaVentures Ltd

Bookmarks

Bookmark PharmaDeals through one of these social networks.